YML108W Antibody

Shipped with Ice Packs
In Stock

Description

Biological Context and Experimental Observations

YML108W was identified in a high-copy suppressor screen designed to alleviate toxicity induced by a nuclear-localized, polyglutamine-expanded huntingtin fragment (Htt103Q-NLS) . The gene was isolated as part of a 5–10 kb genomic fragment (GF7) that suppressed Htt103Q-NLS toxicity in yeast. Key findings include:

  • Mechanism of Suppression: YML108W does not encode a polyglutamine-rich protein, unlike other suppressors (e.g., Pop2, Cbk1). Its suppressive effect is linked to changes in Htt103Q spatial organization, as evidenced by fluorescence microscopy showing reduced nuclear foci formation .

  • Protein Interactions: Co-immunoprecipitation assays indicate that YML108W may interact with Hsp70 and its co-chaperone Sti1, which mediate spatial quality control of amyloid-like proteins .

Gene Expression and Functional Data

  • Expression Profiling: Microarray analysis of yeast cells under galactose-inducing conditions revealed YML108W expression levels of 0.670 (log2 fold change relative to controls) .

  • Genetic Deletion: Deletion of YML108W in the W303α strain (Δyml108w) did not confer overt growth defects under standard laboratory conditions, suggesting it is non-essential for viability .

Relevance to Huntington’s Disease

YML108W’s role in HD models highlights its potential as a modifier of protein aggregation pathways. Huntington’s disease is characterized by toxic polyglutamine expansions in huntingtin (Htt), which form intracellular aggregates. YML108W’s ability to modulate these aggregates suggests it may influence:

  • Amyloid Seeding: YML108W expression reduces the formation of Htt103Q nuclear foci, which are linked to cytotoxicity .

  • Chaperone Networks: Its interaction with Hsp70/Sti1 implies a role in routing misfolded proteins into benign aggregates, mitigating cellular damage .

Current Research Gaps

Despite its identification in HD models, YML108W remains poorly annotated. Key gaps include:

  • Molecular Function: No functional motifs or orthologs have been identified, limiting mechanistic insights .

  • Conservation: Homologs outside S. cerevisiae are absent in ortholog databases (e.g., OrthoMCL), raising questions about its evolutionary significance .

Potential Applications

While YML108W is not directly linked to antibody development, its role in protein quality control pathways suggests utility in:

  • Therapeutic Targeting: Modulators of YML108W-like pathways could enhance chaperone-mediated clearance of toxic protein aggregates in neurodegenerative diseases .

  • Biomarker Discovery: Its expression changes in stress conditions (e.g., 0.670 log2 fold change under galactose induction) may inform diagnostic strategies.

Citations and References

All data cited are derived from peer-reviewed studies:
- Global analysis of SUMO chain function in yeast .
- Polyglutamine-rich suppressors of Huntington’s disease toxicity .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YML108W antibody; YM8339.11 antibody; Uncharacterized protein YML108W antibody
Target Names
YML108W
Uniprot No.

Q&A

What is YML108W and why is it significant in research?

YML108W is a protein in Saccharomyces cerevisiae (Baker's yeast, strain ATCC 204508/S288c) that localizes to the nucleus and is involved in transcriptional processes. The antibody against YML108W serves as an important research tool for studying nuclear processes and transcriptional regulation in yeast models. This protein has been identified in studies examining RNA polymerase function, making it particularly valuable for understanding fundamental transcription mechanisms .

The significance of YML108W lies in its nuclear localization and potential role in co-transcriptional pre-mRNA processing, which provides insights into basic eukaryotic cellular mechanisms that are often conserved across species. Research with YML108W antibody enables scientists to track protein expression, localization, and interactions in experimental systems.

What are the validated applications for YML108W antibody?

YML108W antibody has been validated for several research applications:

ApplicationValidation StatusCommon DilutionsNotes
ELISAValidated1:1000-1:5000Works well for quantitative detection
Western BlotValidated1:500-1:2000Ensures identification of antigen
IHCNot fully validated-Limited data available
IPNot fully validated-Limited data available

Both ELISA and Western Blot methodologies have been thoroughly tested for this antibody, allowing reliable identification and quantification of the target protein in yeast samples . When designing experiments, researchers should prioritize these validated applications while considering appropriate controls, especially when attempting non-validated applications.

What are the optimal storage and handling conditions for YML108W antibody?

Proper storage and handling are crucial for maintaining antibody activity. For YML108W antibody:

  • Store at -20°C or -80°C upon receipt

  • Avoid repeated freeze-thaw cycles that can degrade antibody activity

  • The antibody is supplied in liquid form with 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as preservative

  • Working aliquots should be prepared and stored separately to avoid freeze-thaw cycles of the stock solution

When handling the antibody, maintain cold chain practices and use sterile techniques to prevent contamination. For long-term studies, monitoring antibody activity through regular validation assays is recommended to ensure consistent experimental results.

How should controls be designed for experiments using YML108W antibody?

Robust experimental design with appropriate controls is essential when working with YML108W antibody:

Essential Controls for YML108W Antibody Experiments:

  • Positive Control: Lysate from wild-type S. cerevisiae expressing YML108W

  • Negative Control:

    • Lysate from YML108W knockout strain

    • Secondary antibody only (no primary antibody)

  • Isotype Control: Non-specific rabbit IgG at the same concentration

  • Loading Control: Antibody against a housekeeping protein (e.g., actin) for normalization

When designing experiments, particularly for Western blot analyses, researchers should include both technical and biological replicates to account for variability. Additionally, when working with nuclear proteins like YML108W, subcellular fractionation controls are recommended to verify localization claims 5.

What are the key methodological considerations for optimizing Western blot with YML108W antibody?

Optimizing Western blot protocols for YML108W antibody requires attention to several parameters:

  • Sample Preparation:

    • Use fresh yeast cultures in exponential growth phase

    • Include protease inhibitors during lysis to prevent degradation

    • Consider using specialized nuclear extraction buffers given YML108W's nuclear localization

  • Blocking and Antibody Dilution:

    • Test different blocking agents (5% BSA often performs better than milk for phospho-proteins)

    • Optimize primary antibody dilution (start with 1:1000 and adjust based on signal-to-noise ratio)

    • Incubate primary antibody overnight at 4°C for optimal binding

  • Detection and Troubleshooting:

    • For weak signals, consider longer exposure times or signal enhancement systems

    • For high background, increase washing steps and dilute antibody further

    • If non-specific bands appear, optimize SDS-PAGE conditions and consider adding additional blocking steps

How can YML108W antibody be integrated into multi-parameter experimental designs?

For complex experimental designs investigating transcriptional mechanisms:

  • Co-localization Studies:

    • Combine YML108W antibody with antibodies against other nuclear proteins

    • Use different fluorophore conjugates for simultaneous detection

    • Consider super-resolution microscopy for precise localization

  • Sequential Immunoprecipitation:

    • Use YML108W antibody for first-round IP followed by another antibody for suspected interaction partners

    • This approach helps confirm protein-protein interactions in transcriptional complexes

  • ChIP-Seq Integration:

    • YML108W antibody can be used in chromatin immunoprecipitation followed by sequencing

    • This reveals genomic binding sites and potential regulatory functions

    • Correlation with RNA-Seq data provides functional insights into transcriptional effects

These integrated approaches provide more comprehensive understanding than single-parameter experiments, though they require careful validation of each component method .

How can researchers address YML108W's role in transcriptional complexes?

YML108W's nuclear localization suggests involvement in transcriptional processes. To study its role in transcriptional complexes:

  • Proximity Labeling Techniques:

    • BioID or APEX2 fusion constructs with YML108W can identify neighboring proteins

    • This reveals the protein's immediate interaction network in live cells

  • Co-immunoprecipitation coupled with Mass Spectrometry:

    • Using YML108W antibody for immunoprecipitation followed by MS analysis

    • This identifies stable interaction partners

  • R-loop Analysis using S9.6 Antibody:

    • The S9.6 monoclonal antibody recognizes RNA:DNA hybrids (R-loops)

    • Combined with YML108W studies, this approach can determine if YML108W affects R-loop formation during transcription

  • Genetic Interaction Mapping:

    • Synthetic genetic array analysis with YML108W deletion/mutation

    • Identifies genes functionally related to YML108W through genetic interactions

These methodologies collectively provide a systems-level understanding of YML108W's function in transcriptional regulation and pre-mRNA processing.

What approaches are effective for studying post-translational modifications of YML108W?

Post-translational modifications (PTMs) often regulate nuclear protein functions. For YML108W:

  • Phospho-specific Antibody Development:

    • Generate antibodies against predicted phosphorylation sites

    • Use phosphatase treatments as controls to confirm specificity

  • Mass Spectrometry-based PTM Mapping:

    • Immunoprecipitate YML108W followed by tryptic digestion

    • MS/MS analysis identifies modified residues

    • Quantitative approaches (SILAC, TMT) can compare modification levels between conditions

  • Site-directed Mutagenesis Validation:

    • Create point mutations at putative modification sites

    • Functional assays determine the impact of preventing specific modifications

  • Kinase/Phosphatase Inhibitor Screens:

    • Treat cells with inhibitor panels to identify enzymes regulating YML108W

    • Monitor changes in modification state with the YML108W antibody

These approaches provide complementary information about YML108W regulation through post-translational modifications that may affect its function in transcriptional processes .

How does YML108W relate to paralogs in Pol I and Pol III systems?

YML108W has paralogs in RNA polymerase I and III systems, suggesting evolutionary relationships between these transcriptional machineries:

  • Comparative Immunoprecipitation Studies:

    • Use specific antibodies against YML108W and its paralogs

    • Compare interacting partners to identify shared and unique components

    • This reveals functional conservation and specialization

  • Cross-system Functional Complementation:

    • Express YML108W in paralog-depleted cells

    • Assess rescue of paralog-dependent functions

    • This determines functional interchangeability

  • Evolutionary Analysis Approaches:

    • Phylogenetic comparisons across species

    • Identification of conserved domains and sequence motifs

    • This provides insight into the evolutionary history of these related proteins

Understanding these relationships helps elucidate the broader context of RNA polymerase evolution and functional specialization across different transcriptional systems .

How can researchers resolve inconsistent or contradictory results when using YML108W antibody?

When faced with experimental inconsistencies:

  • Antibody Validation Checks:

    • Confirm antibody lot-to-lot consistency with standard samples

    • Perform epitope blocking experiments to verify specificity

    • Consider using alternative antibody clones if available

  • Sample Preparation Optimization:

    • Standardize cell growth conditions and harvest protocols

    • Ensure complete nuclear extraction for nuclear proteins like YML108W

    • Monitor protein degradation with protease inhibitor cocktails

  • Technical Parameter Analysis:

    • Systematically vary incubation times, temperatures, and buffer compositions

    • Document all experimental conditions meticulously for troubleshooting

    • Implement statistical process control to identify sources of variation

  • Cross-Methodological Validation:

    • Compare results between different antibody-based techniques (ELISA vs. WB)

    • Correlate antibody results with orthogonal methods (e.g., mass spectrometry)

    • This multi-technique approach helps resolve contradictions 5

Careful documentation of all experimental conditions is essential for identifying sources of inconsistency and establishing reproducible protocols.

What statistical approaches are appropriate for analyzing YML108W expression data?

  • Exploratory Data Analysis:

    • Assess data distribution (normal vs. non-normal)

    • Identify outliers using box plots or Grubbs' test

    • Visualize data trends with appropriate plots

  • Appropriate Statistical Tests:

    • For normally distributed data: t-tests (two conditions) or ANOVA (multiple conditions)

    • For non-normally distributed data: non-parametric alternatives (Mann-Whitney, Kruskal-Wallis)

    • For time-course studies: repeated measures ANOVA or mixed-effects models

  • Multiple Testing Correction:

    • Apply Bonferroni or Benjamini-Hochberg procedures

    • Report both uncorrected and corrected p-values

    • Balance Type I and Type II error risks

  • Power Analysis and Sample Size Calculation:

    • Determine required sample size for desired statistical power

    • Consider biological variation when designing experiments

    • Report power calculations in methodology sections5

How can researchers effectively compare results across different antibody-based techniques?

When integrating data from multiple techniques:

  • Standardized Reporting:

    • Report all methodological details including antibody dilutions, incubation times, and detection methods

    • Include relevant controls for each technique

    • Normalize data appropriately within each method

  • Correlation Analysis:

    • Calculate correlation coefficients between techniques

    • Generate Bland-Altman plots to assess systematic differences

    • Identify technique-specific biases

  • Meta-Analytical Approaches:

    • Combine results across techniques using formal meta-analysis

    • Weight evidence based on methodological quality and rigor

    • Produce consensus estimations of YML108W properties

  • Technology-Specific Limitations Documentation:

    • Acknowledge the inherent strengths and weaknesses of each technique

    • Consider technique-specific artifacts in interpretation

    • Use complementary methods to address blind spots of individual techniques 5

This systematic approach to cross-technique comparisons produces more reliable and comprehensive understanding of YML108W's properties and functions.

What emerging technologies show promise for studying YML108W function?

Several cutting-edge approaches can advance YML108W research:

  • CRISPR-Cas9 Genome Editing:

    • Generate precise modifications of YML108W

    • Create tagged versions for live-cell imaging

    • Establish conditional knockout systems for temporal studies

  • Single-Cell Approaches:

    • Single-cell RNA-seq to examine cell-to-cell variation in YML108W-dependent processes

    • Single-cell proteomics to correlate YML108W levels with other proteins

    • This reveals heterogeneity masked in population averages

  • Advanced Imaging Techniques:

    • STORM/PALM super-resolution microscopy for precise localization

    • FRET/FLIM for studying protein-protein interactions in living cells

    • Light-sheet microscopy for long-term dynamic studies

  • Synthetic Biology Approaches:

    • Engineer orthogonal versions of YML108W with controllable properties

    • Create synthetic circuits to probe YML108W function

    • Design protein scaffolds to manipulate YML108W interactions

These emerging technologies offer new ways to interrogate YML108W function with unprecedented precision and context.

How can bispecific antibody technology be applied to YML108W research?

Bispecific antibody technology offers innovative approaches for YML108W studies:

  • Simultaneous Detection Applications:

    • Design bispecific antibodies targeting YML108W and interaction partners

    • This enables co-detection without secondary antibody complications

    • Particularly valuable for multi-color microscopy and flow cytometry

  • Proximity-Based Assays:

    • Create bispecific antibodies linking YML108W to reporter systems

    • This enables functional readouts based on localization or interactions

    • Can be adapted for high-throughput screening applications

  • Design Considerations:

    • Symmetric HC₂LC₂ format provides stable detection but with paired valencies

    • Appropriate linker selection (typically glycine-serine 10-25aa) ensures proper spacing

    • Developability screening identifies constructs with favorable biophysical properties

The application of bispecific antibody technology to YML108W research represents an emerging frontier that combines antibody engineering advances with specific research needs in transcriptional biology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.